Alimera Sciences, Inc. (ALIM) Financial Statements (2024 and earlier)

Company Profile

Business Address 6310 TOWN SQUARE
ALPHARETTA, GA 30005
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,27416,51011,2089,42613,04324,067
Cash and cash equivalents5,27416,51011,2089,42613,04324,067
Restricted cash and investments303434333234
Receivables19,61219,12817,20019,33117,25911,435
Inventory, net of allowances, customer advances and progress billings1,6052,6792,7461,3902,4051,508
Inventory1,6052,6792,7461,3902,4051,508
Other undisclosed current assets2,8923,8093,7182,5652,1092,278
Total current assets:29,41342,16034,90632,74534,84839,322
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization  392 414
Operating lease, right-of-use asset1,3951,7107201,107
Property, plant and equipment2,5252,7831,638 1,3551,410
Intangible assets, net (including goodwill)8,95710,89712,83814,78316,72318,664
Intangible assets, net (excluding goodwill)8,95710,89712,83814,78316,72318,664
Deferred income tax assets129137753734
Other undisclosed noncurrent assets183441 5261,182528
Total noncurrent assets:13,18916,36015,94917,56419,26020,602
TOTAL ASSETS:42,60258,52050,85550,30954,10859,924
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,08612,32310,65811,7939,9989,487
Accounts payable10,0888,7067,4617,0776,3555,905
Accrued liabilities3,9983,6173,1974,7163,6433,582
Debt25,6462691,690255236184
Other undisclosed current liabilities      
Total current liabilities:39,73212,59212,34812,04810,2349,671
Noncurrent Liabilities
Long-term debt and lease obligation18,68343,08042,9229430534,568
Long-term debt, excluding current maturities18,68343,08042,408  34,365
Capital lease obligations305203
Finance lease, liability  51494
Liabilities, other than long-term debt4,9955,4533,5633,9542,974766
Other liabilities4,9955,4533,5633,9542,974766
Operating lease, liability    
Total noncurrent liabilities:23,67848,53346,4854,0483,27935,334
Total liabilities:63,41061,12558,83316,09613,51345,005
Equity
Equity, attributable to parent, including:(20,808)(2,605)(7,978)(4,445)2,72214,919
Common stock70695750701 
Additional paid in capital378,238377,229365,830350,117346,108341,622
Accumulated other comprehensive loss(2,955)(1,849)(553)(1,093)(1,011)(821)
Accumulated deficit(415,388)(397,281)(392,909)(387,570)(377,127)(399,075)
Warrants and rights outstanding  3703,7073,707 
Other undisclosed equity, attributable to parent 19,22719,22719,22730,34430,34473,193
Total equity:(20,808)(2,605)(7,978)(4,445)2,72214,919
Other undisclosed liabilities and equity   38,65837,873 
TOTAL LIABILITIES AND EQUITY:42,60258,52050,85550,30954,10859,924

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues54,12959,02950,82053,94346,97035,912
Cost of revenue
(Cost of Goods and Services Sold)
(7,977)(7,030)(6,941)(6,626) (3,438)
Other undisclosed gross profit     (4,679) 
Gross profit:46,15251,99943,87947,31742,29132,474
Operating expenses(57,792)(52,200)(44,380)(52,591)(51,961)(48,926)
Operating loss:(11,640)(201)(501)(5,274)(9,670)(16,452)
Nonoperating income (expense)
(Gain (Loss), Foreign Currency Transaction, before Tax)
92416474(84)(65)5
Interest and debt expense(5,881)(3,621)(5,380)(4,869)(6,541)(5,579)
Other undisclosed income from continuing operations before equity method investments, income taxes      188
Loss from continuing operations before equity method investments, income taxes:(17,429)(3,406)(5,407)(10,227)(16,276)(21,838)
Other undisclosed loss from continuing operations before income taxes(650)(528)    
Loss from continuing operations before income taxes:(18,079)(3,934)(5,407)(10,227)(16,276)(21,838)
Income tax expense (benefit)(28)(438)68(216)(106)(163)
Loss from continuing operations:(18,107)(4,372)(5,339)(10,443)(16,382)(22,001)
Loss before gain (loss) on sale of properties:(4,372)(5,339)(10,443)(16,382)(22,001)
Net loss attributable to parent:(18,107)(4,372)(5,339)(10,443)(16,382)(22,001)
Preferred stock dividends and other adjustments    38,330 
Undistributed earnings (loss) allocated to participating securities, basic     4,489 
Other undisclosed net loss available to common stockholders, basic     (4,489) 
Net income (loss) available to common stockholders, diluted:(18,107)(4,372)(5,339)(10,443)21,948(22,001)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(18,107)(4,372)(5,339)(10,443)(16,382)(22,001)
Other comprehensive income (loss)    (82)(190)451
Comprehensive loss:(18,107)(4,372)(5,339)(10,525)(16,572)(21,550)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,106)(1,296)540   
Comprehensive loss, net of tax, attributable to parent:(19,213)(5,668)(4,799)(10,525)(16,572)(21,550)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: